Cargando…
Impact of γ-chain cytokines on EBV-specific T cell cultures
BACKGROUND: Recent preclinical adoptive immunotherapy studies in murine models prompt to employ "proper" rather than "as many as possible" antigen-specific T cells to gain better therapeutic results. Ideally, "proper" T cells are poorly differentiated in vitro, but reta...
Autores principales: | Merlo, Anna, Turrini, Riccardo, Trento, Cristina, Zanovello, Paola, Dolcetti, Riccardo, Rosato, Antonio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001712/ https://www.ncbi.nlm.nih.gov/pubmed/21092174 http://dx.doi.org/10.1186/1479-5876-8-121 |
Ejemplares similares
-
Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer
por: Turrini, Riccardo, et al.
Publicado: (2011) -
A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors
por: Turrini, Riccardo, et al.
Publicado: (2017) -
Exploiting the Interplay between Innate and Adaptive Immunity to Improve Immunotherapeutic Strategies for Epstein-Barr-Virus-Driven Disorders
por: Martorelli, Debora, et al.
Publicado: (2012) -
Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies
por: Cappuzzello, Elisa, et al.
Publicado: (2016) -
Survivin Expression and Prognostic Significance in Pediatric Malignant Peripheral Nerve Sheath Tumors (MPNST)
por: Alaggio, Rita, et al.
Publicado: (2013)